Value proposition

Investing at the convergence of biology and engineering to support a new generation of breakthrough companies.

OMX Ventures is a venture capital firm focused on investing in a new era of bioengineering and its application for better tools, medicines, foods, industrial products, and more. We specialize in early-stage investments at the intersection of biology, big data, and AI, with a focus on therapeutics, bio tools, diagnostics, and synthetic biology platforms. We aim to help founders build strong teams, overcome key technical challenges in their first two years of operations, and grow into successful commercial enterprises. Before founding OMX, our partners invested early in successful biotech companies like 10X Genomics (TXG), Twist Bioscience (TWST), Ginkgo Bioworks (DNA), and QuantaLife (now part of Bio-Rad - BIO).

Contact us: info@omx.vc